Jinan High tech Development Co Ltd

Jigao Development disclosed its 2026 semi-annual report on August 29. In the first half, it achieved total operating revenue of 137 million yuan, down 14.05 percent year on year. Net loss attributable to the parent company was 55.86 million yuan, compared with a loss of 46.68 million yuan in the same period last year. Net loss after deducting non-recurring items was 30.61 million yuan, compared with a loss of 26.51 million yuan a year earlier. Net cash flow from operating activities was negative 57.22 million yuan, compared with negative 61.53 million yuan in the prior-year period. Basic loss per share was 0.06 yuan, and the weighted average return on net assets was negative 21.43 percent. The company's main businesses include in vitro diagnostics, trading, and real estate and property services.

Jigao Development disclosed an earnings forecast, expecting a net loss attributable to the parent of 54 million yuan in the first half of 2026, compared with a loss of 46.6766 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 29 million yuan, compared with a loss of 26.5063 million yuan in the same period last year. The company stated that the losses were mainly due to provisions for estimated compensation losses from existing litigation cases, as well as a decline in operating performance affected by the industry. Based on the closing price on July 14, the company's price-to-earnings ratio is approximately negative 9.97 times, the price-to-book ratio is about 7.27 times, and the price-to-sales ratio is about 6.78 times. Jigao Development's main businesses include in vitro diagnostics, trading, real estate, and property services.